2003, Pharmaceuticals and Targeted Protein Degradation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Pharmaceuticals

Targeted Protein Degradation

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

Next, Saleko highligts how Northumberland and the North East of the UK are recognised for pharmaceutical manufacturing prowess. Situated at Surrey University science park and listed on London’s AIM Market since 2003, the market has provided long term support for growing healthcare companies. billion in funding.

Drugs

Drugs Science Therapies Targeted Protein Degradation

Antibody-drug conjugates payloads: then, now and next

Drug Target Review

OCTOBER 4, 2023

Recent efforts are breathing new life into geldanamycin through the construction of a fusion protein made with an anti-HER2 scFv and an HSP90 inhibitor-binding domain (HER2 scFv-HBD), which has resulted in improved anti-cancer efficacy in HER2-positive cancers when loaded with geldanamycin derivatives. 102 , 1–6 (2016). link] Park H-K, et al.

Small Molecule

Small Molecule Drugs Immune Response Targeted Protein Degradation

Drug Discovery Digest

Where is the drug discovery expertise happening in the UK?

Antibody-drug conjugates payloads: then, now and next

Stay Connected